Diabetic Retinopathy News and Research

RSS
In the initial stages, people with diabetic retinopathy may not notice their vision changing. Diabetics sometimes experience rapid changes in blood sugar that can temporarily cause blurry vision even when retinopathy is not present. If a person notices a few specks or spots floating in his visual field, this may mean he has developed proliferative diabetic retinopathy, the growth of abnormal new blood vessels on the retina and optic nerve. High blood sugar levels have been linked in studies to retinal blood vessel abnormalities. Blurred vision may occur when the macula--the small area at the center of the retina--swells as it fills with fluid that has leaked from retinal blood vessels. Because damage to the eye often develops slowly, early detection of diabetes and control of blood sugar through diet and medications can make a crucial difference in saving vision.

Effective diabetic retinopathy treatments include laser photocoagulation for early to moderate stages and a microsurgery called vitrectomy for repair of eyes with extensive damage. Injectable and oral medications that act on abnormal blood vessels to control diabetic retinopathy before vision loss occurs are now in development. Early detection would be key to the effectiveness of these treatments, also.
Patients who undergo gastric bypass less likely to have risk of heart attack and stroke

Patients who undergo gastric bypass less likely to have risk of heart attack and stroke

Gastric bypass dramatically improves multiple cardiovascular risk factors in the long term

Gastric bypass dramatically improves multiple cardiovascular risk factors in the long term

Endocrine Society publishes Clinical Practice Guideline on diabetes and pregnancy

Endocrine Society publishes Clinical Practice Guideline on diabetes and pregnancy

NEI-funded study explores methods to improve diagnosis, treatment of common eye diseases

NEI-funded study explores methods to improve diagnosis, treatment of common eye diseases

Promising technique for treating eye disease proves effective in preclinical studies

Promising technique for treating eye disease proves effective in preclinical studies

Allegro receives FDA IND approval to initiate Phase II clinical studies of ALG-1001 in AMD, VMT patients

Allegro receives FDA IND approval to initiate Phase II clinical studies of ALG-1001 in AMD, VMT patients

Diabetic retinopathy incidence in upward trend

Diabetic retinopathy incidence in upward trend

Sun Pharma, Intrexon partner to develop controllable gene-based therapies for ocular diseases

Sun Pharma, Intrexon partner to develop controllable gene-based therapies for ocular diseases

New laser provides better treatment for eye diseases in diabetes patients

New laser provides better treatment for eye diseases in diabetes patients

ThromboGenics, Bicycle to develop and commercialize novel drugs for ophthalmic diseases

ThromboGenics, Bicycle to develop and commercialize novel drugs for ophthalmic diseases

Regeneron, Bayer report positive results from Phase 3 VIVID-DME and VISTA-DME trials of EYLEA for DME

Regeneron, Bayer report positive results from Phase 3 VIVID-DME and VISTA-DME trials of EYLEA for DME

University of Florida receives RPB Sanders Construction grant

University of Florida receives RPB Sanders Construction grant

Researchers discover new protein that encourages ‘bad’ blood vessel growth

Researchers discover new protein that encourages ‘bad’ blood vessel growth

'Sleep Mask' prototype: The world's first non-invasive treatment for sight loss

'Sleep Mask' prototype: The world's first non-invasive treatment for sight loss

New data suggest PaQ device can reduce known barriers to insulin therapy among people with type 2 diabetes

New data suggest PaQ device can reduce known barriers to insulin therapy among people with type 2 diabetes

Ico Therapeutics completes Phase 2 iDEAL study for treatment of diabetic macular edema

Ico Therapeutics completes Phase 2 iDEAL study for treatment of diabetic macular edema

Novel method introduced for detecting retinal micro-aneurysms that pose high risk for leakage

Novel method introduced for detecting retinal micro-aneurysms that pose high risk for leakage

Research on total anomalous pulmonary venous connection

Research on total anomalous pulmonary venous connection

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.